Neglected diseases often affect people living in developing countries. As a result, pharmaceutical companies have little interest in working to find a cure for these diseases. Stimulating awareness about the urgent need for new, better treatment and tests for diseases like leishmaniasis, sleeping sickness and Chagas disease is key to the work of MSF’s Access Campaign and the Drugs for Neglected Diseases Initiative (DNDi) of which MSF was a founding partner.
Patients with neglected tropical diseases (NTDs) need better access to diagnosis and to treatment that is safe and effective
As well as providing healthcare to people affected by the cyclone and flooding disaster, MSF deployed four GIS (Geographic Information Systems) experts to provide maps to help the humanitarian response.
Neglected diseases often affect people living in developing countries. As a result, pharmaceutical companies have little interest in working to find a cure for these diseases. Stimulating awareness about the urgent need for new, better treatment and tests for diseases like leishmaniasis, sleeping sickness and Chagas disease is key to the work of MSF’s Access Campaign and the Drugs for Neglected Diseases Initiative (DNDi) of which MSF was a founding partner.
